Report Feature
The future of the cell viability assay market looks promising with opportunities in academic and research institutes, pharmaceutical and biotechnology companies, and hospitals and diagnostic laboratories. The global cell viability assay market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are increasing cell-based assay research & development and rising incidence and prevalence of chronic and infectious diseases.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global cell viability assay market report, please download the report brochure.
In this market, consumables is the largest product of cell viability assay, whereas pharmaceutical and biotechnology companies is the largest end user. Growth in various segments of the cell viability assay market are given below:
The study includes trends and forecast for the global cell viability assay market by product, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Consumables
- Instruments
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Basic Research
- Stem Cell Research
- Drug Discovery & Development
- Clinical & Diagnostic Applications
- Other Applications
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostic Laboratories
- Other End Users
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Spain
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the cell viability assay model companies profiled in this report include Thermo Fisher Scientific, Bio-Rad Laboratories, Merck, GE Healthcare, Danher, Abcam, BioTek Instruments, PerkinElmer, and Promega Corporation.
Lucintel forecasts that consumbales will remain the largest product segment over the forecast period due to growing investments by government bodies and private sector organizations in research activities that are focused on developing new treatments for various human diseases.
Within this market, pharmaceutical and biotechnology companies will remain the largest segment by end user over the forecast period due to the increasing number of R&D activities undertaken by these companies for the development of biopharmaceutical products.
North America will remain the largest region over the forecast period due to growing incidences of various infectious diseases, investment initiatives by governments, and the high-quality infrastructure for clinical and laboratory research in the region.
|
Features of the Global Cell Viability Assay Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global cell viability assay market by product (consumables and instruments), application (basic research, stem cell research, drug discovery & development, clinical & diagnostic applications, and other applications), end user (academic and research institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, and other end users), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global cell viability assay market? Q.5 What are the business risks and threats to the global cell viability assay market? Q.6 What are the emerging trends in this cell viability assay market and the reasons behind them? Q.7 What are some changing demands of customers in this cell viability assay market? Q.8 What are the new developments in this cell viability assay market? Which companies are leading these developments? Q.9 Who are the major players in this cell viability assay market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this cell viability assay market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global cell viability assay market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Consumables and Instruments), Application (Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, and Other Applications), and End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Other End Users) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Cell Viability Assay Market
4.1 Global Cell Viability Assay Market by Region
4.2.1 Market by Product: Consumables and Instruments
4.2.2 Market by Application: Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, and Other Applications
4.2.3 Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Other End Users
4.2.4 The United States Cell Viability Assay Market
4.2.5 The Canadian Cell Viability Assay Market
4.2.6 The Mexican Cell Viability Assays Market
4.3.1 Market by Product: Consumables and Instruments
4.3.2 Market by Application: Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, and Other Applications
4.3.3 Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Other End Users
4.3.4 The United Kingdom Cell Viability Assay Market
4.3.5 The Spanish Cell Viability Assay Market
4.3.6 The German Cell Viability Assay Market
4.3.7 The French Cell Viability Assay Market
4.4.1 Market by Product: Consumables and Instruments
4.4.2 Market by Application: Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, and Other Applications
4.4.3 Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Other End Users
4.4.4 The Chinese Cell Viability Assay Market
4.4.5 The Indian Cell Viability Assay Market
4.4.6 The Japanese Cell Viability Assay Market
4.5.1 Market by Product: Consumables and Instruments
4.5.2 Market by Application: Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, and Other Applications
4.5.3 Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Other End Users
4.5.4 Brazilian Cell Viability Assay Market
7.1.1 Growth Opportunities for the Global Cell Viability Assay Market by Product
7.1.2 Growth Opportunities for the Global Cell Viability Assay Market by Application
7.1.3 Growth Opportunities for the Global Cell Viability Assay Market by End User
7.1.4 Growth Opportunities for the Global Cell Viability Assay Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
